Bottom line
INVN vs SHPAX: the short answer
INVN (Alger Russell Innovation ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
INVN is cheaper at 0.55% vs 3% — a difference of $245 a year per $10,000 invested.
SHPAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
INVN vs SHPAX side by side
| INVN | SHPAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Alger | Saratoga Advantage |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.55% | 3% |
| Annual cost per $10k | $55 | $300 |
| 10-yr cost on $10k (prospectus) | $1,495 | $3,702 |
| Max front load | None | 5.75% |
| 12b-1 fee | 0% | — |
| 1-yr return | — | −5.5% |
| 5-yr return (annualized) | — | +3.1% |
| 10-yr return (annualized) | — | +4.1% |
| Best quarter | — | +15.0% |
| Worst quarter | — | −13.0% |
| Net assets (fund) | $9.6M | $10.5M |
| Number of holdings | 51 | 29 |
| Portfolio turnover | 68% | 22% |
| Returns as of | — | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
5 of INVN's top 25 holdings also appear in SHPAX's top 25.
| Holding | INVN | SHPAX |
|---|---|---|
| Merck & Company Inc | 2.12% | 3.63% |
| Incyte Corp | 2.11% | 2.89% |
| Bristol-myers Squibb Company | 2.03% | 3.07% |
| Regeneron Pharmaceuticals Inc | 2.03% | 3.93% |
| Exelixis Inc | 2.03% | 4.55% |
Source: SEC Form N-PORT
INVN top 10
- Roblox Corp — 2.57%
- Zebra Technologies Corp — 2.38%
- Expedia Group Inc — 2.29%
- Maplebear Inc — 2.25%
- Block Inc — 2.24%
- Zscaler Inc — 2.22%
- Bill Holdings Inc — 2.19%
- Biogen Inc — 2.18%
- Ccc Intelligent Solutions Holdings Inc — 2.15%
- Etsy Inc — 2.15%
SHPAX top 10
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%
FAQ
What is the difference between INVN and SHPAX?
Which is cheaper, INVN or SHPAX?
Should I own both INVN and SHPAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.